A Closer Look At The Research Behind MIRE Therapy
- Volume 20 - Issue 7 - July 2007
- 13015 reads
- 0 comments
1. Harkless LB, Delellis, Carnegie DH, Burke TJ. Improved foot sensitivity and pain reduction in patients with peripheral neuropathy after treatment with monochromatic infrared photo energy. J Diabetes Compl 20(2006) 81-87.
2. Powell MW, Carnegie DE, Burke TJ. Reversal of diabetic neuropathy and new wound incidence: the role of MIRE. Adv Skin Wound Care 17:295-300, 2004.
3. Powell MW, Carnegie DE, Burke TJ. Reversal of diabetic neuropathy and new wound incidence: the role of MIRE. Adv Skin Wound Care 17:295-300, 2004.
4. DeLellis SL, Carnegie DH Burke TJ. Improvement of sensitivity in patients with peripheral sensory neuropathy. J Am Podiatr Med Assoc 95: 143-147, 2005.
5. Prendergrast JJ, Miranda G, Sanchez M. Improvement sensory impairment in patients with peripheral sensory neuropathy. Endocr Prac 10: 24-30, 2004.
6. Kochman AB, Carnegie DH, Burke TJ. Symptomatic reversal of peripheral neuropathy in patients with diabetes. J Am Podiatr Med Assoc, 2002. 92(3):125-30.
7. Leonard DR, Farooqi MH, Myers S. Restoration of sensation, reduced pain, and improved balance in subjects with diabetic peripheral neuropathy: a double-blind, randomized, placebo-controlled study with monochromatic near-infrared treatment. Diabetes Care, 2004. 27(1):168-72.
8. Arnall DA, et al. The restorative effects of pulsed infrared light therapy on significant loss of peripheral protective sensation in patients with long-term type 1 and type 2 diabetes mellitus. Acta Diabetol, 2006. 43(1):26-33.
9. Clifft JK, et al. The effect of monochromatic infrared energy on sensation in patients with diabetic peripheral neuropathy: a double-blind, placebo-controlled study. Diabetes Care, 2005. 28(12):2896-900.
10. Yong R, et al. The durability of the Semmes-Weinstein 5.07 monofilament. J Foot Ankle Surg, 2000. 39(1):34-8.
11. McGill M, et al. Possible sources of discrepancies in the use of the Semmes-Weinstein monofilament. Impact on prevalence of insensate foot and workload requirements. Diabetes Care, 1999. 22(4):598-602.
12. Booth J, Young MJ. Differences in the performance of commercially available 10-g monofilaments. Diabetes Care, 2000. 23(7):984-8.
13. Armstrong DG, Lavery LA, Quebedeaux TL, Fleishli JG, Vela S: Choosing a Practical Screening Instrument to Identify Patients at Risk for Diabetic Foot Ulceration. Arch Int Med 158: 289-292, 1998.
14. Diamond JE, et al. Reliability of a diabetic foot evaluation. Phys Ther, 1989. 69(10):797-802.
15. Mueller MJ, et al. Insensitivity, limited joint mobility, and plantar ulcers in patients with diabetes mellitus. Phys Ther, 1989. 69(6):453-9; discussion 459-62.